324 related articles for article (PubMed ID: 27610139)
1. The Progress and Prospects of Putative Biomarkers for Liver Cancer Stem Cells in Hepatocellular Carcinoma.
Xiang Y; Yang T; Pang BY; Zhu Y; Liu YN
Stem Cells Int; 2016; 2016():7614971. PubMed ID: 27610139
[TBL] [Abstract][Full Text] [Related]
2. Research Progress on Regulating LncRNAs of Hepatocellular Carcinoma Stem Cells.
Zhang X; Zhu Y
Onco Targets Ther; 2021; 14():917-927. PubMed ID: 33603396
[TBL] [Abstract][Full Text] [Related]
3. Targeting liver cancer stem cells for the treatment of hepatocellular carcinoma.
Li N; Zhu Y
Therap Adv Gastroenterol; 2019; 12():1756284818821560. PubMed ID: 30719075
[TBL] [Abstract][Full Text] [Related]
4. Cancer stem cells in hepatocellular carcinoma: an overview and promising therapeutic strategies.
Wang N; Wang S; Li MY; Hu BG; Liu LP; Yang SL; Yang S; Gong Z; Lai PBS; Chen GG
Ther Adv Med Oncol; 2018; 10():1758835918816287. PubMed ID: 30622654
[TBL] [Abstract][Full Text] [Related]
5. Surface markers of liver cancer stem cells and innovative targeted-therapy strategies for HCC.
Qiu L; Li H; Fu S; Chen X; Lu L
Oncol Lett; 2018 Feb; 15(2):2039-2048. PubMed ID: 29434903
[TBL] [Abstract][Full Text] [Related]
6. [Novel therapeutic strategies for treatment of hepatocellular carcinoma: targeting intervention on liver cancer stem cells].
Li X; Luo Q; Song G
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2013 Aug; 30(4):894-8. PubMed ID: 24059077
[TBL] [Abstract][Full Text] [Related]
7. The power and the promise of liver cancer stem cell markers.
Liu LL; Fu D; Ma Y; Shen XZ
Stem Cells Dev; 2011 Dec; 20(12):2023-30. PubMed ID: 21651381
[TBL] [Abstract][Full Text] [Related]
8. Research progress and prospects of markers for liver cancer stem cells.
Zhu CP; Wang AQ; Zhang HH; Wan XS; Yang XB; Chen SG; Zhao HT
World J Gastroenterol; 2015 Nov; 21(42):12190-6. PubMed ID: 26576103
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA in liver cancer stem cells.
Cai Z; Xu K; Li Y; Lv Y; Bao J; Qiao L
Discov Med; 2017 Sep; 24(131):87-93. PubMed ID: 28972877
[TBL] [Abstract][Full Text] [Related]
10. Actinomycin D inhibits the expression of the cystine/glutamate transporter xCT via attenuation of CD133 synthesis in CD133
Song Y; Park IS; Kim J; Seo HR
Chem Biol Interact; 2019 Aug; 309():108713. PubMed ID: 31226288
[TBL] [Abstract][Full Text] [Related]
11. Musashi2 contributes to the maintenance of CD44v6+ liver cancer stem cells via notch1 signaling pathway.
Wang X; Wang R; Bai S; Xiong S; Li Y; Liu M; Zhao Z; Wang Y; Zhao Y; Chen W; Billiar TR; Cheng B
J Exp Clin Cancer Res; 2019 Dec; 38(1):505. PubMed ID: 31888685
[TBL] [Abstract][Full Text] [Related]
12. Emerging Regulatory Mechanisms Involved in Liver Cancer Stem Cell Properties in Hepatocellular Carcinoma.
Lv D; Chen L; Du L; Zhou L; Tang H
Front Cell Dev Biol; 2021; 9():691410. PubMed ID: 34368140
[TBL] [Abstract][Full Text] [Related]
13. Targeting cancer stem cells as a therapeutic approach in liver cancer.
Zhou G; Wilson G; George J; Qiao L
Curr Gene Ther; 2015; 15(2):161-70. PubMed ID: 25537770
[TBL] [Abstract][Full Text] [Related]
14. Autophagy contributes to the survival of CD133+ liver cancer stem cells in the hypoxic and nutrient-deprived tumor microenvironment.
Song YJ; Zhang SS; Guo XL; Sun K; Han ZP; Li R; Zhao QD; Deng WJ; Xie XQ; Zhang JW; Wu MC; Wei LX
Cancer Lett; 2013 Oct; 339(1):70-81. PubMed ID: 23879969
[TBL] [Abstract][Full Text] [Related]
15. Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells.
Huo X; Han S; Wu G; Latchoumanin O; Zhou G; Hebbard L; George J; Qiao L
Mol Cancer; 2017 Oct; 16(1):165. PubMed ID: 29061150
[TBL] [Abstract][Full Text] [Related]
16. Krüppel-like factor 8 promotes cancer stem cell-like traits in hepatocellular carcinoma through Wnt/β-catenin signaling.
Shen YN; He HG; Shi Y; Cao J; Yuan JY; Wang ZC; Shi CF; Zhu N; Wei YP; Liu F; Huang JL; Yang GS; Lu JH
Mol Carcinog; 2017 Feb; 56(2):751-760. PubMed ID: 27478926
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-302a/d inhibits the self-renewal capability and cell cycle entry of liver cancer stem cells by targeting the E2F7/AKT axis.
Ma YS; Lv ZW; Yu F; Chang ZY; Cong XL; Zhong XM; Lu GX; Zhu J; Fu D
J Exp Clin Cancer Res; 2018 Oct; 37(1):252. PubMed ID: 30326936
[TBL] [Abstract][Full Text] [Related]
18. Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells.
Wang R; Sun Q; Wang P; Liu M; Xiong S; Luo J; Huang H; Du Q; Geller DA; Cheng B
Oncotarget; 2016 Feb; 7(5):5754-68. PubMed ID: 26735577
[TBL] [Abstract][Full Text] [Related]
19. Regulators of liver cancer stem cells.
Liu K; Ou JJ
World J Stem Cells; 2021 Aug; 13(8):1127-1133. PubMed ID: 34567430
[TBL] [Abstract][Full Text] [Related]
20. ELK3 promotes the migration and invasion of liver cancer stem cells by targeting HIF-1α.
Lee JH; Hur W; Hong SW; Kim JH; Kim SM; Lee EB; Yoon SK
Oncol Rep; 2017 Feb; 37(2):813-822. PubMed ID: 27959451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
